Tag: cancer

American oncologists take money from pharmaceutical companies for pure greed

Imagine if your car mechanic took $10,000 a year from Michelin tyres for “consulting” and then tended to recommend their tyres over Pirelli – even if the latter are on sale or better quality or both.

Imagine if your Governor took campaign contributions from Panera bread and then strangely exempted Panera bread from the new minimum wage law.

Imagine if your cancer doctor took money from Karyopharm and then prescribed the toxic poison selenexor (studied in the unethical trial Boston) over safer and cheaper alternatives.

To my knowledge, the first example didn’t happen. The second example is why people think Politicians are sleazy, and the last example is the norm in medicine.

Each year, cancer doctors – particularly academic doctors – take tens of millions in pharma payments while simultaneously writing guidelines that mandate the use of these drugs and simultaneously prescribing them to desperate sick patients who want an objective opinion, but get a biased one instead.

85% of National Comprehensive Cancer Network guidelines writers take pharma payments, and professional organisations are awash in Pharma cash. The American Society of Clinical Oncology (“ASCO”) – our annual meeting – is less about the objective appraisal of science and more a marketing conference for Pharma.

I don’t want to rehash the data showing taking money from Pharma is associated with greater, inappropriate, off-label prescribing, hype, spin and editorials favourable to the sponsor. There is a lot of literature there, and I have written about it extensively. Here, I want to address three things doctors who take personal payments say in rebuttal.

Keep reading

DNA Contamination in Pfizer COVID Shot 500 Times Permissible Level: New Study

Genetic impurities in the Pfizer mRNA COVID vaccine could be as high as 500 times the permissible limit, according to a new study.

In the study, published in Methods and Protocols, two German researchers raise worrying questions about the reliability of the quantitative PCR technique used by Pfizer-BioNTech to measure DNA contamination in the vaccine.

Using their own tests on the vaccine’s lipid nanoparticles, they discovered levels that were between 360 and 534 times higher than the 10 nanogram per dose limit set by regulators.

The researchers argued that the methods used by Pfizer-BioNTech test for only 1% of the original DNA template used to make the vaccine, meaning that 99% of the genetical material from the template therefore goes untested and potentially undetected.

Similar concerns have been raised by other researchers.

Keep reading

Pfizer agrees to settle 10,000 lawsuits accusing pharma giant of hiding cancer risks of heartburn drug Zantac

Pfizer has agreed to settle more than 10,000 lawsuits alleging it it of hiding the cancer risks of its heartburn drug Zantac.

The financial details have not been revealed but pharma rival Sanofi agreed to pay more than $100million to resolve 4,000 Zantac-cancer claims last nonth.

The over-the-counter pill was pulled in the US in 2020 after animal studies found a key ingredient released ‘probable human carcinogens’.

Pfizer was the primary manufacturer of Zantac from 1998 to 2006, when several suits claim it should have known that the drug was contaminated with NDMA.

Plaintiffs claimed the drug was contaminated with the impurity through improper manufacturing practices, and that Pfizer withheld this information from consumers.

NDMA is a chemical byproduct of many industrial manufacturing processes, including the production of rocket fuel.

Keep reading

Just four types of cancer made up half of the 1.96 million cancer cases in the U.S. in 2023

Half of the 1.96 million cancer cases diagnosed in the United States in 2023 were just four different types of cancer – breast cancer, prostate cancer, lung and bronchus cancer and colorectal cancer.

According to the nonprofit organization USAFacts, 15 percent each of cancer cases are breast cancer and prostate cancer. Another 12 percent of cases are lung or bronchus cancer, while eight percent are colorectal cancers.

Cancer deaths also rose to 609,820 in 2023. Lung and bronchus cancer cases alone made up 21 percent of all cancer-related deaths. Nine percent of cancer deaths were from colorectal cancer, pancreatic cancer made up eight percent and breast cancer seven percent.

The rise of colorectal cancer has been especially concerning, given that the number of colorectal cancer cases has risen by a whopping 15 percent over the past decade, theorized to be due to increasingly unhealthy lifestyles of Americans impacting gut health.

Data from USAFacts indicates that colorectal cancer cases account for eight percent of all cancer cases in the United States. Studies also show that around four percent of all men and women in the U.S. will develop colon cancer in their lifetime.

In younger demographics – ages 15 to 39 – the most common types of new cancers are breast cancer (15 percent), thyroid (15 percent), testis (eight percent) and melanoma of the skin (seven percent).

Keep reading

Turbo cancer in New York

Executive summary

Cancer cases are up by 2.5X in New York state Medicaid vs. a 2017-2019 baseline.

Is this normal? Absolutely not! This is a very serious problem.

Isn’t it awesome that they keep these numbers confidential? And that nobody in the mainstream press will look into this?

The data

You can examine the data: NY Medicaid ICD-10 Cxx codes data (2019-2023) (the link downloads the xlsx spreadsheet).

Cancers with the highest increase

The ratio column is the ratio vs. counts in the 2019 baseline.

Overall, there was a 2.5X increase over baseline.

Some cancers got better vs. baseline, others got worse. The odds that a given cancer code got worse were 25:1.

Note that the rates of increase strongly depends on the type of cancer. This means that they can’t use the excuse that this is all because people didn’t get treated for their cancers during the Covid lockdowns. It that were the case, the increases would be the roughly the same for all cancer types, not dramatically different.

Keep reading

Cancer risk from covid vaccines; medicine regulators failed the public catastrophically

The covid vaccines skipped safety testing for cancer risk. Pfizer said genotoxicity, carcinogenicity and biodistribution studies were “not considered necessary.” Even while their trial info sheet said: “Due to the urgent need for a vaccine against covid-19, with agreement from the MHRA, some of the tests usually required for a newly manufactured vaccine have been modified, in order to make the vaccine available more quickly for assessment.” 

There are numerous reasons to be concerned about a potential cancer risk. Cancer occurs when mutations in DNA mean that cell growth is no longer controlled. The body has plenty of safety nets to minimise the risk of cancer developing but the accumulation of damage can reach a tipping point where cancer results. The balance can also be tipped towards cancer if the immune system stops killing the malignant cells. The whole process can take many years to develop but it needn’t. 

The vaccines can hypothetically contribute to that outcome in multiple ways:

  • Constant production of a mixture of foreign proteins will lead to chronic inflammation and potentially immune exhaustion.
  • Modified nucleotides increase the risk of cancer.
  • Spike protein damaging genes that protect cells from cancer.
  • Contaminant DNA that can integrate into the recipient’s DNA and damage protective genes or else enhance growth-promoting genes.

Keep reading

Top D.A.R.E. Officer Says Medical Marijuana Helped His Brother-In-Law Treat Cancer Pain

The anti-drug group D.A.R.E.’s 2022 officer of the year asserts in a new online documentary that “alcohol is a gateway drug”—though he occasionally drinks it. But marijuana is another story and can’t be safely enjoyed recreationally, he says, despite believing that cannabis has medical value after it helped treat his brother-in-law’s cancer-related pain.

D.A.R.E.’s president, meanwhile, acknowledges in the documentary that some of the criticism of the war on drugs might have something to do with earlier scandals within federal agencies, such as the CIA’s implication in a cocaine-smuggling conspiracy that he described as an “unfortunate part of our history.”

As the decades-old program works to reshape its image and move away from its scaremongering anti-drug roots under the Reagan administration, the leaders of the group convened for an international conference in Las Vegas last year where independent journalist Andrew Callaghan spoke to them about contemporary drug policy issues.

The interviews are featured in a documentary for the Callahan’s YouTube program Channel 5 that was released this month.

One of the more notable conversations involved Alex Mendoza, the 2022 D.A.R.E. officer of the year, who has worked to redefine the program’s approach to youth drug prevention.

“For me, it’s really about educating the youth that are out there—to give them the tools necessary to navigate whatever pain that they’re going through” that might lead to substance misuse, he said. “I think that if you don’t have that self-love for yourself and that resiliency, then you’re gonna go to that external source, whatever that might be.”

Keep reading

Confirmed: Researchers Reveal COVID mRNA Vaccines Contain Component that Suppresses Immune Response and Stimulates Cancer Growth

A comprehensive review by an international consortium of scientists has raised serious concerns about the COVID-19 mRNA vaccines’ safety profile.

Review articles are summaries of current research on a particular topic. They are also sometimes called literature reviews or secondary sources.

The review, “N1-methyl-pseudouridine (m1Ψ): Friend or foe of cancer?” published on Science Direct, delves into the potential implications of a vaccine ingredient—N1-methyl-pseudouridine (m1Ψ)—that may play a role in immune suppression and cancer proliferation.

m1Ψ was incorporated into Pfizer-BioNTech’s COVID-19 mRNA vaccine to enhance its efficacy.

This component was introduced in the mRNA vaccine as a means to produce a significant amount of modified SARS-CoV-2 spike mRNA through in vitro transcription (IVT). This modification was crucial in the rapid development and deployment of the vaccine during the height of the pandemic.

However, the review article calls into question the long-term impacts of this modification, especially concerning the vaccine’s interaction with the body’s immune response and potential carcinogenic effects.

According to the review’s abstract, evidence suggests that while mRNA vaccines may have been “effective” in reducing severe disease outcomes, they might not provide sterilizing immunity, leaving individuals susceptible to recurring infections.

More critically, the review highlights that the inclusion of m1Ψ in mRNA vaccines appears to inhibit key immunological pathways, impairing the body’s early interferon signaling.

Keep reading

COVID Vaccines have caused at least 14,000% increase in Cancer Cases in the USA according to CDC

Figures published by the US Centers for Disease Control (CDC) have confirmed that the COVID-19 vaccines have caused at least a 14,000% increase in cancer cases in the USA up to the end of March 2024. With data revealing a minimum 6,113% increase in cancer cases among children and young adults.

The figures have been surmised by comparing cancer cases caused by the COVID-19 vaccines to the Influenza vaccines due to the lack of data published by the CDC that allows us to surmise the number of cancer cases via other methods.

According to the CDC Vaccine Adverse Event Reporting System (VAERS) just 8 cancer cases were linked to the many influenza vaccines on offer between the 1st January 2021 and 29th March 2024. Whereas 497 cancer cases were connected to the few COVID-19 vaccines on offer during the same time frame. This equates to a 6,113% increase in cancer cases due to COVID-19 vaccination.

Keep reading

Data Analyst Reveals Shocking Increase In Cancer Deaths Following COVID-19 Injection Rollout

Edward Dowd, a data analyst, revealed shocking data on the Dr. Drew show Wednesday, indicating a significant and troubling increase in cancer deaths, particularly in the 75 to 84 age group, following the rollout of COVID-19 injections.

Carlos Alegria and Yuri Nunes of Phinace Technologies unveil the concerning trend in cancer deaths among elderly individuals in their latest report.

Dowd informed Dr. Kelly Victory, a board-certified trauma and emergency specialist with over 30 years of clinical experience, that “there was no signal in 2020.” However, he noted a “clear deviation” in 2021 and 2022.

“We found something interesting,” he said.

There was a historical decrease in underlying cancer deaths from 2010 to 2019 per 100,000 people, which was primarily attributed to cancer itself, Vigilant News highlights.

Underlying cancer deaths maintained the trend in 2020 and decreased to approximately 1,021 deaths per 100,000 people. However, cancer deaths increased to 1,049 per 100,000 in 2021 and further rose to 1,091 per 100,000 in 2022.

The data from 2022 reveals a 6.85% increase in underlying cancer mortality rates per 100,000 people compared to 2020. This increase marks a reversal of the longstanding trend of declining cancer death rates. 

Keep reading